Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03527966 · ClinicalTrials.gov registry record · Phase 4
rhBMP-2 Versus Vivigen in Lumbar Fusion Procedures
A Phase 4 study, sponsored by Virtua Health.
- Terminated
- Registry status
- Phase 4
- Development phase
- 3
- Enrollment target
NCT03527966 is a Phase 4 study that was terminated before completion, run by Virtua Health. The registered enrollment target is 3 participants.
The verdict
NCT03527966, a Phase 4 study, was terminated before completion, sponsored by Virtua Health.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 3 participants
- Enrollment target
Study Summary
This study is aimed at comparing the overall efficacy (clinical and radiographic) of Vivigen, a novel cellular allograft product, and rhBMP-2 when utilized in lumbar fusion procedures.
Interventions
- BIOLOGICAL 5cc Vivigen and local autograft
- BIOLOGICAL Small kit rhBMP-2 with local autograft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2017-07-03 |
| Est. Completion | 2018-07-27 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03527966
The ClinicalTrials.gov registry entry for NCT03527966 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virtua Health, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 5cc Vivigen and local autograft is the first listed.
NCT03527966 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03527966 about?
NCT03527966 is a clinical study titled "rhBMP-2 Versus Vivigen in Lumbar Fusion Procedures". This study is aimed at comparing the overall efficacy (clinical and radiographic) of Vivigen, a novel cellular allograft product, and rhBMP-2 when utilized in lumbar fusion procedures.
What is the current status of trial NCT03527966?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 3 participants. The study started on 2017-07-03. Estimated completion is 2018-07-27.
What interventions are being tested in trial NCT03527966?
The interventions under investigation include: 5cc Vivigen and local autograft (BIOLOGICAL), Small kit rhBMP-2 with local autograft (BIOLOGICAL).
Who is sponsoring clinical trial NCT03527966?
This trial is sponsored by Virtua Health, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.